Company Profile

Macrocure Ltd. is a clinical-stage biopharmaceutical company focused on developing a novel therapeutic platform to address chronic and hard-to-heal wounds, such as diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs).

Read More

NASDAQ: MCUR

$ 1.74
- 0.27 (-13.43%)
Day High: 2.05
Day Low:  1.71
Volume:    1,301,276
4:00 PM ET on Aug 30, 2016

Delayed at least 20 minutes.